1. Home
  2. LCTX vs EDHL Comparison

LCTX vs EDHL Comparison

Compare LCTX & EDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCTX
  • EDHL
  • Stock Information
  • Founded
  • LCTX 1990
  • EDHL 2021
  • Country
  • LCTX United States
  • EDHL Hong Kong
  • Employees
  • LCTX N/A
  • EDHL N/A
  • Industry
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • EDHL
  • Sector
  • LCTX Health Care
  • EDHL
  • Exchange
  • LCTX Nasdaq
  • EDHL NYSE
  • Market Cap
  • LCTX 107.3M
  • EDHL 128.0M
  • IPO Year
  • LCTX N/A
  • EDHL 2025
  • Fundamental
  • Price
  • LCTX $0.70
  • EDHL $5.10
  • Analyst Decision
  • LCTX Strong Buy
  • EDHL
  • Analyst Count
  • LCTX 5
  • EDHL 0
  • Target Price
  • LCTX $4.20
  • EDHL N/A
  • AVG Volume (30 Days)
  • LCTX 1.5M
  • EDHL 96.5K
  • Earning Date
  • LCTX 08-07-2025
  • EDHL 01-01-0001
  • Dividend Yield
  • LCTX N/A
  • EDHL N/A
  • EPS Growth
  • LCTX N/A
  • EDHL N/A
  • EPS
  • LCTX N/A
  • EDHL 0.14
  • Revenue
  • LCTX $9,557,000.00
  • EDHL $2,761,798.00
  • Revenue This Year
  • LCTX N/A
  • EDHL N/A
  • Revenue Next Year
  • LCTX $232.66
  • EDHL N/A
  • P/E Ratio
  • LCTX N/A
  • EDHL $33.64
  • Revenue Growth
  • LCTX 19.42
  • EDHL N/A
  • 52 Week Low
  • LCTX $0.37
  • EDHL $3.51
  • 52 Week High
  • LCTX $1.15
  • EDHL $5.30
  • Technical
  • Relative Strength Index (RSI)
  • LCTX 62.72
  • EDHL N/A
  • Support Level
  • LCTX $0.48
  • EDHL N/A
  • Resistance Level
  • LCTX $0.83
  • EDHL N/A
  • Average True Range (ATR)
  • LCTX 0.06
  • EDHL 0.00
  • MACD
  • LCTX 0.01
  • EDHL 0.00
  • Stochastic Oscillator
  • LCTX 60.76
  • EDHL 0.00

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

About EDHL EVERBRIGHT DIGITAL HOLDING

Everbright Digital Holding Ltd is an integrated marketing solutions provider in Hong Kong that is involved in the metaverse and related technologies, and is providing one-stop digital marketing services for the process of enterprise development. Its digital marketing solutions include metaverse stimulation, virtual reality (VR) and augmented reality (AR) design and creation, creative event planning and management, IP character creation and social media marketing.

Share on Social Networks: